Jose Antonio Moreno Toscano is the current LFB USA & rEVO Biologics Chief Executive Officer, bringing significant global leadership experience to the Company.

Prior to joining LFB, Jose served as President of Safe Harbor Compliance and Clinical Services, where he is also a Board member. He also led the US & Canadian subsidiaries of ALK, a publicly held Danish company that is the world leader in allergy and immunotherapy care. He held full P&L and operational responsibility for ALK’s Americas region, successfully growing the top and bottom line via both organic growth and accretive acquisitions.  Prior to his role at ALK, Jose served as Chief Financial Officer for Applus A/S in Copenhagen.  He began his career in Corporate Development and Investor Relations, where he led M&A activities at Chr. Hansen Holding, a world leader in biosciences focused on developing and commercializing ingredients for the food, agricultural and pharmaceutical industries.  

Jose brings a global perspective to our business, having lived and worked in several European countries as well as the US.  Jose earned his Master’s Degree in Law from the Universidad de Murcia in Spain and his MBA in International Finance and Strategy from the ENPC School of International Management in Paris.

Team Member Image: 

Chief Executive Officer